The University of Virginia’s Department of Physical Medicine and Rehabilitation is currently enrolling people who have suffered a stroke for a research study supported by the National Institutes of Health. The purpose of the research study is to investigate the initial efficacy and safety of a new system for stroke rehabilitation called GRASP. GRASP allows patients to practice activities of daily living using a computer and a specialized glove for therapy.
ENHANCED MELANOMA VACCINE AGAINST NEEOANTIGEN AND SHARED ANTIGENS BY CD40 ACTIVATION AND TLR AGONISTS IN PATIENTS WITH MELANOMA (MEL 66)
The UVA Center for Diabetes Technology seeks adults aged 21-65 years for a research study. You may be eligible for this study if you have had type 1 diabetes for more than a year and wear a Tandem insulin pump.
The purpose of this study is to test a computer program that might give additional information to users with type 1 diabetes about their blood glucose control and insulin changes. The program does this by allowing users to simulate changes to their diabetes treatment decisions. The program then shows the possible blood glucose outcomes of those changes.
A Phase 1, Open-Label, Dose Finding, First-in-Human Study to Determine the Safety, Pharmacokinetics and Efficacy of KPG-121 when Administered with Enzalutamide, Abiraterone, or Apalutamide in Subjects with Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
A pilot randomized study of lymphocyte depletion and change in lymphocyte functionality during lung Stereotactic Body Radiation Therapy (SBRT) treatment by selectively reducing irradiation of circulating blood compared to standard of care control group